Literature DB >> 11076212

Brain abscess at the University Hospital of the West Indies.

G Donaldson1, D Webster, I W Crandon.   

Abstract

Surgical infections of the central nervous system are still attended by high rates of morbidity and mortality, although substantial progress has been made since the advent of computed tomography (CT) scanning technology. In this retrospective review of 25 surgically treated patients with either brain abscess or subdural empyema at the University Hospital of the West Indies, the majority of patients were male and between the ages of 10 and 30 years with a mean age of 16.9 years. Almost half the patients had a hemiparesis on presentation while 60% had fever. Subdural empyema was more common than a localized intracerebral abscess which was most frequently located in the frontal lobe. The most common predisposing factors were sinusitis and congenital heart disease. Streptococci spp and Staphylococci spp were the most frequently isolated organisms. All patients underwent CT scanning and surgical intervention. The mortality rate was 20%, and 21% of the survivors had late seizures. There must be a high index of clinical suspicion and early referral to specialist centres where neuroradiological investigation and prompt neurosurgical intervention can be carried out to minimize morbidity and mortality.

Entities:  

Mesh:

Year:  2000        PMID: 11076212

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  2 in total

1.  [Management of encephalic abscess: series of 82 cases].

Authors:  Fahd Derkaoui Hassani; Nizare El Fatemi; Faycal Moufid; Mohammed YassadOudrhiri; Rachid Gana; Rachid El Maaqili; Fouad Bellakhdar
Journal:  Pan Afr Med J       Date:  2014-06-04

2.  Management of Brain Abscess: Changing Trend and Experience in Enugu, Nigeria.

Authors:  Chika Anele Ndubuisi; Samuel C Ohaegbulam; Wilfred C Mezue; Mark C Chikani; Sunday P Nkwerem; Ignatius I Ozor
Journal:  Niger J Surg       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.